Market Place
Sourcing Support
Akums Drugs & Pharma posts Q2 FY25 adjusted PAT at Rs. 66.7 Cr
11 Nov 2024 //
INDPHARMAPOST
Akums to empower mothers with Doxylamine + Pyridoxine extended-release tablets
28 Dec 2023 //
INDIAN PHARMA POST
Akums, Lyrus Life Sciences collaborate for patented technologies and formulations
22 Feb 2023 //
ECONOMIC-TIMES
Akums receives DCGI approval for type 2 diabetes drug to improve insulin resistance
06 Feb 2023 //
BIOSPECTRUM ASIA
Akums chalks out expansion plan as it eyes Rs 10K cr turnover by 2028
27 Nov 2022 //
HEALTH ET
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.